North America Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others)
Market Introduction
North America is the largest market for point of care diagnostics. The region includes US, Canada, and Mexico. The growth of the North America market is characterized by the growing prevalence of infectious diseases, government support for advanced diagnostics kits and instruments, and increasing efforts in R&D activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to be a major growth stimulator for the point of care diagnostics market in North America. In US, Centers for Medicare and Medicaid Services (CMS) directs Medicare, which is a federal program for adults aged above 65 and people with disabilities, and it works along with state governments. CMS maintain both Medicaid and the Children’s Health Insurance Program (CHIP), an assembly of federal-state programs for various low-income people. Medicare delivers coverage for physician services, hospitalization, and a voluntary supplementary program, prescription drugs. Additionally, the presence of top revenue-generating medical device companies that can invest a significant amount in R&D supports the market growth as these companies manufacture innovative medical devices.
In case of COVID-19, North America is highly affected specially the US. The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the point of care diagnostics market. Significant population of North America is infected with coronavirus. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies engaged in development of novel drugs for the treatment of life threaten diseases. In addition, increasing demand for rapid testing equipment is also playing a prominent role in the growth of the North America point of care diagnostics market. Furthermore, due to the rising numbers of COVID-19 population has positive impact on the adoption of point of care diagnostic kits. This adoption is boosting new product development and launches in the market. For instance, in July 2020, Eurofins U.S. Clinical Diagnostics has announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients. Moreover, in March 2020, Abbott received FDA approval for its molecular point-of-care test for the diagnosis of COVID-19. The test is capable to deliver positive results in five minutes and negative result in less than fifteen minutes. Such product launches are expected to accelerate the growth of the North America point of care diagnostics market.
Get more information on this report :
Market Overview and Dynamics
The North America point of care diagnostics market is expected to grow from US$ 16,612.40 million in 2021 to US$ 38,702.11 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Various conferences and events are held to make people aware about devices and give overview of the common key principles that should be applied when establishing and maintaining point-of-care testing (POCT) services. Participants in these conferences/events can utilize these learnings to develop a framework for introducing POCT for a specific clinical need relevant to their family practice. In June 2019, SELECTBIO held the Point-of-Care, Biosensors & Mobile Diagnostics conference. The Emerging Trends and Themes in Point-of-Care Diagnostics and Mobile Diagnostics, Commercialization of Microfluidic Devices for Point-of-Care Applications, and Paper-based Analytical Devices for the Diagnosis and Monitoring of Infectious Diseases at the Point of Care were the major topics covered in this conference. So, burgeoning number of conferences and events is expected to escalate the market growth.
Key Market Segments
In terms of product, the glucose monitoring products segment accounted for the largest share of the North America point of care diagnostics market in 2020. In terms of prescription mode, the prescription-based testing segment held a larger market share of the North America point of care diagnostics market in 2020. Further, the professional diagnostic centers segment held a larger share of the North America point of care diagnostics market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America point of care diagnostics market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; Johnson and Johnson Services, Inc.; Nova Biomedical; Polymer Technology Systems, Inc. (PTS); and Siemens AG.
Reasons to buy report
- To understand the North America point of care diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America point of care diagnostics market
- Efficiently plan M&A and partnership deals in North America point of care diagnostics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America point of care diagnostics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Point of Care Diagnostics Market Segmentation
North America Point of Care Diagnostics Market - By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
North America Point of Care Diagnostics Market - By Prescription Mode
- Prescription-Based Testing
- OTC Testing
North America Point of Care Diagnostics Market - By End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
North America Point of Care Diagnostics Market - By Country
- US
- Canada
- Mexico
North America Point of Care Diagnostics Market - Company Profiles
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Point of Care Diagnostics Market – By Product
1.3.2 North America Point of Care Diagnostics Market – By Prescription Mode
1.3.3 North America Point of Care Diagnostics Market – By End User
1.3.4 North America Point of Care Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
5. North America Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Infectious Diseases
5.1.2 Increasing Product Launches and Product Developments
5.1.3 Rising Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Product Recalls in Market
5.3 Market Opportunities
5.3.1 Burgeoning Number of Conferences and Events
5.4 Future Trends
5.4.1 Escalating Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – North America Analysis
6.1 North America Point of Care Diagnostics Market Revenue Forecast and Analysis
7. North America Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 North America Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. North America Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 North America Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. North America Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 North America Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. North America Point of Care Diagnostics Market – Country Analysis
10.1 North America: Point of Care Diagnostics Market
10.1.1 Overview
10.1.2 North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 US: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 US: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 US: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 US: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 US: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Canada: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Canada: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Canada: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Canada: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Mexico: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 Mexico: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 Mexico: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 Mexico: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Point of Care Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. US: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 4. US: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. US: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Organic Developments the Point of Care Diagnostics Market
Table 18. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Point of Care Diagnostics Market Segmentation
Figure 2. North America Point of Care Diagnostics Market Segmentation, By Country
Figure 3. North America Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of Point of North America Care Diagnostics Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to North America Point of Care Diagnostics Market
Figure 8. North America Point of Care Diagnostics Market – Revenue Forecast and Analysis
Figure 9. North America Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. North America Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. North America Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. North America Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. North America Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. North America Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. North America Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. North America Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. North America Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. North America Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. North America OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. North America Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. North America Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. North America Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. North America Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. North America Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. North America Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. North America Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. North America Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. North America: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 41. North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Mexico Point of care diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
Figure 45. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America point of care diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in North America point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the point of care diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution